Camryn J. Fulton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Camryn J. Fulton has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Amy E. Moritz
Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA
1 shared publicationAshley N. Nilson
Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA
1 shared publication- Chun-Hsing Chen
University of North Carolina at Chapel Hill
1 shared publication - David R. Sibley
NINDS/NIH
1 shared publication Feijun Wang
Chemical Biology and Medicinal Chemistry Division, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
1 shared publicationJayachandra Rayadurgam
Chemical Biology and Medicinal Chemistry Division, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
1 shared publication
Latest Publications
- Open Access
- 12 August 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (37) , 39744-39756
Synthesis and systematic evaluation of four stereoisomers of BMS compound A enabled by a diastereoselective cyclopropanation on a chiral ketal intermediate
The D 1 dopamine receptor (D 1 R) ligand BMS Compound A is a positive allosteric modulator (PAM) of D 1 R signaling.
- 12 August 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (37) , 39744-39756
Open AccessSynthesis and systematic evaluation of four stereoisomers of BMS compound A enabled by a diastereoselective cyclopropanation on a chiral ketal intermediate
The D 1 dopamine receptor (D 1 R) ligand BMS Compound A is a positive allosteric modulator (PAM) of D 1 R signaling.